Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.03T
Market cap1.03T
Price-Earnings ratio
40.56
Price-Earnings ratio40.56
Dividend yield
0.55%
Dividend yield0.55%
Average volume
2.97M
Average volume2.97M
High today
$1,128.77
High today$1,128.77
Low today
$1,095.06
Low today$1,095.06
Open price
$1,125.41
Open price$1,125.41
Volume
816.42K
Volume816.42K
52 Week high
$1,149.10
52 Week high$1,149.10
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,096.31, giving the company a market capitalization of 1.03T. It carries a P/E multiple of 40.56 and pays a dividend yield of 55.3%.

On 2026-05-29, Eli Lilly(LLY) stock traded between a low of $1,095.06 and a high of $1,128.77. Shares are currently priced at $1,096.31, which is +0.1% above the low and -2.9% below the high.

The Eli Lilly(LLY)'s current trading volume is 816.42K, compared to an average daily volume of 2.97M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,149.10 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,149.10 and a 52-week low of $623.78.

LLY News

Reuters 4h
Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients - Reuters

...

Lilly's Mounjaro tops other GLP-1s for some type 2 diabetes patients - Reuters
Sherwood News 19h
Stocks close at new records

Axios reported that that the US and Iran have reached a tentative deal to extend the ceasefire by 60 days, pending President Trump’s approval. The S&P 500, Nas...

Stocks close at new records
The Wall Street Journal 19h
Eli Lilly Stock on Track for Record as Insurance Coverage Expands for Zepbound

Eli Lilly shares are on pace to hit a new all-time closing high on news of increased insurance coverage for its blockbuster weight-loss drug Zepbound. Lilly sh...

Eli Lilly Stock on Track for Record as Insurance Coverage Expands for Zepbound

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

MarketWatch 20h
Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Eli Lilly’s stock is on track for a record close after the drugmaker disclosed that one of the nation’s most powerful pharmacy-benefit managers will start cover...

Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
MarketWatch 21h
Eli Lilly is on pace for its first record close of 2026

Eli Lilly is on pace for its first record close of 2026 Eli Lilly was up 3.7% on Thursday, trading around $1,123 a share. If this level holds, the pharmaceutic...

Eli Lilly is on pace for its first record close of 2026
TipRanks 22h
Lilly to present new Foundayo, Mounjaro and retatrutide data at ADA meeting

Eli Lilly (LLY) will present new data across its cardiometabolic portfolio at the American Diabetes Association’s 86th Scientific Sessions taking place June 5-8...

Nasdaq 23h
Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now

Key Points Eli Lilly is performing very well as a business right now, which should please shareholders. Novo Nordisk has fallen behind Eli Lilly in the GLP-1...

Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now
TipRanks 1d
Eli Lilly Stock Jumps 5% as CVS Health Covers Its Weight-Loss Drugs

The stock of Eli Lilly (LLY) is up 5% on May 28 after CVS Health (CVS) announced that it is restoring coverage of the company’s weight-loss injection Zepbound a...

TipRanks 1d
Eli Lilly reports PBMs to cover full obesity medicine portfolio

Eli Lilly (LLY) announced all three of the nation’s largest pharmacy benefit managers, or PBMs, will cover Lilly’s full obesity medicine portfolio. This signifi...

CNBC 1d
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. CVS Health on Thursday said it will re...

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.